| Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site C Pargellis, L Tong, L Churchill, PF Cirillo, T Gilmore, AG Graham, ... Nature structural biology 9 (4), 268-272, 2002 | 1053 | 2002 |
| Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase S Kubicek, RJ O'Sullivan, EM August, ER Hickey, Q Zhang, ML Teodoro, ... Molecular cell 25 (3), 473-481, 2007 | 931 | 2007 |
| Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate J Regan, S Breitfelder, P Cirillo, T Gilmore, AG Graham, E Hickey, B Klaus, ... Journal of medicinal chemistry 45 (14), 2994-3008, 2002 | 421 | 2002 |
| Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase KC Qian, L Wang, ER Hickey, J Studts, K Barringer, C Peng, A Kronkaitis, ... Journal of Biological Chemistry 280 (7), 6130-6137, 2005 | 320 | 2005 |
| Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea … J Regan, A Capolino, PF Cirillo, T Gilmore, AG Graham, E Hickey, ... Journal of medicinal chemistry 46 (22), 4676-4686, 2003 | 166 | 2003 |
| Aromatic heterocyclic compound as antiinflammatory agents PF Cirillo, TA Gilmore, ER Hickey, JR Regan, LH Zhang US Patent 6,319,921, 2001 | 144 | 2001 |
| The kinetics of binding to p38 MAP kinase by analogues of BIRB 796 J Regan, CA Pargellis, PF Cirillo, T Gilmore, ER Hickey, GW Peet, A Proto, ... Bioorganic & medicinal chemistry letters 13 (18), 3101-3104, 2003 | 126 | 2003 |
| Compounds useful as anti-inflammatory agents S Breitfelder, PF Cirillo, TA Gilmore, ER Hickey, JR Proudfoot, JR Regan, ... US Patent 6,358,945, 2002 | 98 | 2002 |
| Aromatic heterocyclic compounds and their use as anti-inflammatory agents JR Regan, PF Cirillo, ER Hickey, N Moss, CL Cywin, C Pargellis, ... US Patent 6,080,763, 2000 | 89 | 2000 |
| Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode K Qian, L Wang, CL Cywin, BT Farmer, E Hickey, C Homon, S Jakes, ... Journal of medicinal chemistry 52 (7), 1814-1827, 2009 | 81 | 2009 |
| Ligands for the Tyrosine Kinase p56lck SH2 Domain: Discovery of Potent Dipeptide Derivatives with Monocharged, Nonhydrolyzable Phosphate Replacements PL Beaulieu, DR Cameron, JM Ferland, J Gauthier, E Ghiro, J Gillard, ... Journal of medicinal chemistry 42 (10), 1757-1766, 1999 | 78 | 1999 |
| Compounds which modulate the CB2 receptor R Zindell, D Riether, DS Thomson, ER Hickey, I Mushi, M Ermann US Patent 7,595,397, 2009 | 74 | 2009 |
| Direct elaboration of complex polyquinanes through twofold addition of vinyl anions to squarate esters J Negri, T Morwick, J Doyon, PD Wilson, ER Hickey, LA Paquette Journal of the American Chemical Society 115 (25), 12189-12190, 1993 | 72 | 1993 |
| An in silico method for predicting Ames activities of primary aromatic amines by calculating the stabilities of nitrenium ions J Bentzien, ER Hickey, RA Kemper, ML Brewer, JD Dyekjær, SP East, ... Journal of chemical information and modeling 50 (2), 274-297, 2010 | 70 | 2010 |
| Isoquinolinone Rho kinase inhibitors T Bosanac, JD Ginn, ER Hickey, TM Kirrane Jr, W Liu, AS Prokopowicz, ... US Patent 8,809,326, 2014 | 69 | 2014 |
| A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo ND Lewis, LA Patnaude, J Pelletier, DJ Souza, SM Lukas, FJ King, JD Hill, ... PLoS One 9 (6), e100883, 2014 | 66 | 2014 |
| Compounds useful as anti-inflammatory agents S Breitfelder, PF Cirillo, MH Hao, ER Hickey, R Sharma, S Sun, ... US Patent 6,492,393, 2002 | 63 | 2002 |
| G Protein–Coupled Bile Acid Receptor 1 Stimulation Mediates Arterial Vasodilation through a KCa1. 1 (BKCa)–Dependent Mechanism RM Fryer, KJ Ng, SGN Mazurek, L Patnaude, DJ Skow, A Muthukumarana, ... Journal of Pharmacology and Experimental Therapeutics 348 (3), 421-431, 2014 | 53 | 2014 |
| Compounds which modulate the CB2 receptor A Berry, PF Cirillo, D Riether, D Thomson, RM Zindell, N Blumire, ... US Patent 7,928,123, 2011 | 49 | 2011 |
| Pyrimidine derivatives useful as inhibitors of PKC-theta AJM Barbosa Jr, SR Brunette, ER Hickey, JM Kim, MD Lawlor, ... US Patent 7,601,714, 2009 | 44 | 2009 |
